Kairos Pharma, Ltd. Share Price
AMEX: KAPA | Micro CapKairos Pharma, Ltd. Stock Performance
Kairos Pharma, Ltd. Share Price Today
As of 31 October 2026, Kairos Pharma, Ltd.'s share price is $0.54. The stock opened at $0.53, compared to its previous close of $0.55. During today's trading session, Kairos Pharma, Ltd.'s share price traded between $0.53 and $0.53, with an average price of $0.53. Over the past 52 weeks, the stock has recorded a high of $2.15 and a low of $0.22. In terms of performance, Kairos Pharma, Ltd.'s share price has declined by 5.30% over the last six months and is down 51.15% on a year-on-year basis.
Kairos Pharma, Ltd. Share Price Chart
Kairos Pharma, Ltd. Quarterly Profit & Loss
All figures in USD
Kairos Pharma, Ltd. Annual Profit & Loss
All figures in USD
About Kairos Pharma, Ltd.
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
Kairos Pharma, Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.55 | $0.53 | -68.63% |
Sep 2026 | $1.59 | $1.68 | +594.21% |
Aug 2026 | $0.30 | $0.24 | -22.68% |
Jul 2026 | $0.37 | $0.31 | -19.74% |
Jun 2026 | $0.50 | $0.39 | -22.16% |
May 2026 | $0.56 | $0.50 | -12.11% |
Apr 2026 | $0.55 | $0.57 | +1.60% |
Mar 2026 | $0.62 | $0.56 | -8.18% |
Feb 2026 | $0.68 | $0.61 | -10.15% |
Jan 2026 | $0.72 | $0.68 | -4.36% |
Dec 2025 | $0.79 | $0.71 | -5.07% |
Nov 2025 | $1.06 | $0.75 | -32.22% |